Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Quick read · Open to everyone

“Will It Go Away?” What to Expect From Rheumatology Care

Olga Goodman, MD · A RheumaView publication · 5 October 2026

Almost every new patient asks me some version of the same question, usually near the end of the visit, with one hand already on the door: “Will this go away?”

For many chronic inflammatory rheumatic diseases, the condition can be brought under control and kept there, often for many years, with ongoing treatment. That is good news. It is also a different answer from the one most people hope for, and the distance between the two causes a great deal of avoidable trouble: medications stopped a few weeks too early, a single bad day taken as proof of failure, a year lost looking for a cure that nobody can offer.

Four conditions serve as examples here: rheumatoid arthritis, axial spondyloarthritis, lupus and gout.

What treatment aims for

Treatment works toward a defined target. In rheumatoid arthritis the goal is sustained remission, or low disease activity when remission is not achievable, together with prevention of further joint damage. In axial spondyloarthritis the aim is inactive or low disease activity and preserved function. In lupus the aim is remission or low disease activity, prevention of organ damage, and the lowest feasible steroid dose. Gout has a measurable target: blood uric acid held below 6 mg/dL (about 360 µmol/L), or sometimes lower in severe disease. Over time, maintaining the target allows crystals to dissolve and attacks to become less frequent or stop.

Feeling well usually means the medication is working

Remission and cure are different things. When the disease goes quiet, the medication is usually what is keeping it quiet. Doses can sometimes be lowered slowly under supervision. Stopping on your own tends to end in a flare, and in gout the uric acid simply climbs back.

Most of these medications are slow

Methotrexate needs 6 to 12 weeks. Biologics are judged at about three months. Hydroxychloroquine in lupus can take two to three months, sometimes longer. Gout medication lowers uric acid within weeks, yet attacks may continue, or briefly increase, during the first months while old crystals dissolve. People who were not warned about this often stop the very drug that would have ended their attacks. Your doctor will reassess progress during that period; worsening disease or important side effects should be reported earlier.

The first medication is also frequently not the last. Moving to a second or third option is an ordinary step in treatment and says nothing bad about you or your disease.

What treatment usually cannot do

Established structural damage usually cannot be fully reversed, and a spine that has already fused does not become unfused. Treatment is far better at preventing further damage than rebuilding a damaged joint. Immune treatment also does not reliably relieve pain from osteoarthritis, old injury or fibromyalgia. That pain is real and can be treated by other means. Fatigue may improve slowly or remain even when inflammation is controlled.

Expecting too little is also a mistake

Many people arrive with a picture of a grandmother’s deformed hands or an uncle bent forward at the waist. Those pictures belong to an era before current treatments. With early diagnosis and steady care, most people with these conditions keep working, exercising and traveling, and most women who want children can have them with advance planning. If your joints are still swollen or your back still wakes you at night, that is something to report, because it can usually be improved.

Three questions for your next visit

  • What are we aiming for, and how will we measure it?
  • When should this medication start working, and when do we decide that it has not?
  • Which of my symptoms come from inflammation, and which from something else?

The detailed version of this article covers timelines for specific medications, what blood tests and X-rays can and cannot show, medication safety, diet and supplements, and the signs that a treatment plan needs to be reconsidered. It is free after sign-in.

This material provides general education and does not replace individual medical advice. Discuss treatment changes with your own clinician; do not stop prescribed medication based on this article.

Read the detailed guide →

Related reading & tools

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: GoutHow treatment worksLupusMedication safetyPain and remissionPatient educationRheumatoid arthritisSpondyloarthritisTreatmentTreatment decisionsVisit preparation